LifeStyle
-
Samsung releases eco-friendly protoype toilet for global social contribution initiative
SEOUL -- Samsung researchers regard an eco-friendly toilet developed for a global social contribution initiative as "potentially life-changing" for billions of people who lack safe sanitation, especially those living in crowded urban areas in regions that are flood-prone, or where land, water, and resources for infrastructure are scarce. It is efficient for mass production and can promote sustainable and profitable sanitation services and businesses in poor urban setting
26 August 2022
-
S. Korean researchers find treatment of potato virus Y
SEOUL -- South Korean researchers have developed the treatment of potato virus Y (PVY), which is one of the most important plant viruses affecting potato production. They will push for the transfer of technology to a private company after increasing efficacy and safety by 2024. PVY is transmitted through grafting, plant sap inoculation and mostly through aphid transmission. Global warming has led to an increase in aphid numbers and viral distribution. A research center affiliated w
24 August 2022
-
Celltrion concludes CMO deal for Teva's raw material medicine
SEOUL -- Celltrion, a leading biotech company in South Korea, has concluded a new deal with its Israeli partner, Teva Pharmaceuticals, for the consignment production of raw material medicine for Fremanezumab, a medication used to prevent migraines in adults. The deal for a contract manufacturing organization (CMO) that serves other companies to provide comprehensive services from development through manufacturing is worth 110 billion won ($82.8 million). The contract period is fr
19 August 2022
-
GI Innovation secures patent in Japan for allergy treatment drug candidate GI-301
SEOUL -- A material patent for GI-301, an allergy treatment drug candidate developed by South Korea's bio-venture company GI Innovation, has been registered in Japan where pollen allergy diseases are widespread. The company would try to accelerate technology transfer to Japanese pharmaceutical companies. GI-301 is a biologic for the treatment of allergic diseases, including atopic dermatitis and chronic idiopathic. Yuhan, a pharmaceutical and chemical company in South Korea, s
18 August 2022
-
Samsung Biologics completes first commercial-scale engineering run for mRNA COVID-19 vaccine
SEOUL -- Samsung Biologics, a leading bio company affiliated with South Korea's largest Samsung Group, has completed the first commercial-scale engineering run for the substance production of mRNA COVID-19 vaccines in partnership with technology transfer from its American partner, GreenLight Biosciences. GreenLight, a biotechnology company dedicated to making ribonucleic acid (RNA) products, forged a strategic partnership with Samsung Biologics in late 2021 on a contract manufac
2 August 2022
-
Researchers discover new microorganism capable of decomposing oxybenzone
SEOUL -- South Korean researchers have discovered a microorganism that can multiply without oxygen and decompose oxybenzone, an organic component of many sunscreen lotions. It can be easily cultivated and used to clean up wastewater because of its no pathogenic nature. Oxybenzone provides broad-spectrum ultraviolet coverage. When used at high concentrations, it irritates and damages the skin and eyes, limiting the blending limit. There have been studies that linked coral damage to o
27 July 2022
-
Convenience store chain GS25 opens recyclable container-type unmanned store
SEOUL -- For workers at an oil refinery, South Korea's convenience store chain GS25 has used a recyclable container to open an unmanned store where customers choose products and pay for themselves using QR codes and credit cards. Access is controlled through dedicated apps. The unmanned store erected at a GS Caltex factory in the southern port city of Yeosu used a container of about 18 square meters with electricity and lighting facilities to display about 500 kinds of food and
25 July 2022
-
KT accepts Medi Plus Solutions as new partner for telemedicine service in Vietnam
SEOUL -- As a new business partner for its telemedicine service in Vietnam, KT has allied with Medi Plus Solution, a mobile healthcare solution company affiliated with South Korea's Hyundai shipbuilding group, to develop and provide non-face-to-face management services for cancer patients in the Southeast Asian country. Under as a memorandum of understanding, KT and Medi Plus Solution would jointly develop non-face-to-face patient management services, verify services through loc
20 July 2022
